Neurimmune is a biotech company translating human immune memory into next generation antibody therapeutics. Neurimmune’s pipeline includes human antibody programs for degenerative diseases of the central nervous system such as AD, PD and ALS, as well as for cardiomyopathy and type-2 diabetes.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2006
  • Number of employees in Switzerland
    20-49
Key business